Lingling Fang1, Fangjian Guo2, Lihua Zhou3, Richard Stahl3, Jayleen Grams4. 1. School of Medicine; Zhejiang University ; Hangzhou, China ; Ningbo Medical Center Lihuili Hospital ; Ningbo, China. 2. Department of Nutrition Sciences; University of Alabama at Birmingham ; Birmingham, AL, USA. 3. Department of Surgery; University of Alabama at Birmingham ; Birmingham, AL, USA. 4. Department of Surgery; University of Alabama at Birmingham ; Birmingham, AL, USA ; Birmingham Veterans Administration Medical Center ; Birmingham, AL, USA.
Abstract
AIMS/HYPOTHESIS: Regional deposition of adipose tissue and adipocyte morphology may contribute to increased risk for insulin resistance. The aim of this study was to compare adipocyte cell size and size distribution from multiple fat depots and to determine the association with type 2 diabetes mellitus, anthropomorphic data, and subjects' metabolic profile. METHODS: Clinical data and adipose tissue from subcutaneous fat, omentum, and mesentery were collected from 30 subjects with morbid obesity. Adipocytes were isolated by collagenase digestion and sized by microscopic measurement of cell diameter. RESULTS: Overall, adipocytes from subcutaneous fat were larger than those from omentum or mesentery. For the subcutaneous and omental fat depots, there was a significant increase in % small cells (14.9% vs 31.4%, p = 0 .006 and 14.0% vs 30.5%, p = 0 .015, respectively) and corresponding decrease in % large cells for nondiabetic vs diabetic patients. There was a similar trend for mesentery but it did not reach statistical significance (p = 0 .090). For omentum and mesentery, there was also a significant decrease in the diameter of the small cells. Fasting glucose was positively correlated with fraction of small cells in omentum and mesentery, and HbA1C was positively correlated with fraction of small cells in the omental fat depot. There was no correlation between large cell diameter with clinical parameters in any of the fat depots. CONCLUSIONS/ INTERPRETATION: These results indicate size distribution of adipocytes, specifically an increase in the fraction of small cells, is associated with the presence of type 2 diabetes mellitus.
AIMS/HYPOTHESIS: Regional deposition of adipose tissue and adipocyte morphology may contribute to increased risk for insulin resistance. The aim of this study was to compare adipocyte cell size and size distribution from multiple fat depots and to determine the association with type 2 diabetes mellitus, anthropomorphic data, and subjects' metabolic profile. METHODS: Clinical data and adipose tissue from subcutaneous fat, omentum, and mesentery were collected from 30 subjects with morbid obesity. Adipocytes were isolated by collagenase digestion and sized by microscopic measurement of cell diameter. RESULTS: Overall, adipocytes from subcutaneous fat were larger than those from omentum or mesentery. For the subcutaneous and omental fat depots, there was a significant increase in % small cells (14.9% vs 31.4%, p = 0 .006 and 14.0% vs 30.5%, p = 0 .015, respectively) and corresponding decrease in % large cells for nondiabetic vs diabeticpatients. There was a similar trend for mesentery but it did not reach statistical significance (p = 0 .090). For omentum and mesentery, there was also a significant decrease in the diameter of the small cells. Fasting glucose was positively correlated with fraction of small cells in omentum and mesentery, and HbA1C was positively correlated with fraction of small cells in the omental fat depot. There was no correlation between large cell diameter with clinical parameters in any of the fat depots. CONCLUSIONS/ INTERPRETATION: These results indicate size distribution of adipocytes, specifically an increase in the fraction of small cells, is associated with the presence of type 2 diabetes mellitus.
Authors: Xiaolin Yang; Per-Anders Jansson; Ivan Nagaev; Maia M Jack; Eugenia Carvalho; Katharina Stibrant Sunnerhagen; Margaret C Cam; Samuel W Cushman; Ulf Smith Journal: Biochem Biophys Res Commun Date: 2004-05-14 Impact factor: 3.575
Authors: T McLaughlin; A Sherman; P Tsao; O Gonzalez; G Yee; C Lamendola; G M Reaven; S W Cushman Journal: Diabetologia Date: 2007-06-05 Impact factor: 10.122
Authors: Lauren K Meyer; Theodore P Ciaraldi; Robert R Henry; Alan C Wittgrove; Susan A Phillips Journal: Adipocyte Date: 2013-05-07 Impact factor: 4.534
Authors: Asra N Shaik; Katrin Kiavash; Karri Stark; Julie L Boerner; Julie J Ruterbusch; Hany Deirawan; Sudeshna Bandyopadhyay; Rouba Ali-Fehmi; Gregory Dyson; Michele L Cote Journal: Breast Cancer Res Treat Date: 2020-10-28 Impact factor: 4.872